查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1634206

全球子宮鏡市場 - 2025 - 2033

Global Hysteroscopes Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球子宮腔鏡市場達到2.604億美元，預計2033年將達到4.240億美元，2025-2033年預測期間複合年成長率為5.6%。

子宮腔鏡是一種用於對子宮內部進行目視檢查的醫療儀器。它是一種專為婦科手術設計的內視鏡。該裝置由薄的管狀結構組成，可以透過子宮頸（子宮下部）插入子宮。它通常配備光源和鏡頭，使醫生可以在監視器上即時查看子宮內膜。子宮腔鏡檢查通常在門診或醫院在局部或全身麻醉下進行，具體取決於手術的複雜程度。子宮腔鏡經由子宮頸插入子宮，可使用二氧化碳或鹽水溶液擴張子宮以提高可見度。

受婦科疾病盛行率上升和子宮腔鏡微創手術不斷進步等因素的推動，子宮鏡市場正經歷顯著成長。例如，2024 年 5 月，女性健康醫療器材領域的主要領導者 Meditrina 宣布 FDA 510(k) 批准其第 2 代雙極射頻子宮腔鏡系統。該新系統採用雙極射頻技術和名為 Aveta Glo 的新型雙極射頻設備，代表了微創婦科手術的重大進步。

市場動態：

驅動程式和限制

婦科疾病盛行率上升

婦科疾病盛行率的上升極大地推動了子宮腔鏡市場的成長，預計將在預測期內推動市場成長。子宮肌瘤、子宮內膜息肉和異常子宮出血是常見的婦科疾病，通常需要子宮鏡評估和治療。由於年齡、生活方式的改變和意識的提高等因素，這些疾病的全球發病率正在上升。

例如，根據美國國立衛生研究院 (NIH) 的數據，子宮肌瘤是女性最常見但尚未充分研究的疾病之一。這些腫瘤通常稱為肌瘤，主要影響育齡期的女性，高達 70% 的白人女性和超過 80% 的非裔女性在一生中被診斷出。此外，根據 DynaMed 報告，子宮內膜息肉在患有異常子宮出血的停經後患者中佔 21%-28%，在患有異常子宮出血的停經前患者中佔 10%-40%。

子宮內膜癌（子宮內膜癌）變得越來越常見，尤其是在停經後女性。例如，根據世界癌症研究基金會的數據，2022年子宮內膜癌新發病例為420,368例，其中中國為77,722例，美國為66,055例，俄羅斯為29,852例，日本為18,338例，印度為17,240例。子宮腔鏡檢查是檢測子宮內膜癌的關鍵診斷工具，其在活體組織切片和子宮內膜異常生長評估中的應用至關重要，這增加了對先進子宮鏡系統的需求。

併發症的風險

子宮腔鏡手術相關併發症的風險是阻礙子宮鏡市場成長的重要因素。雖然子宮腔鏡檢查通常被認為是微創且安全的，但它仍然存在一定的風險，可能會阻止患者和醫療保健提供者選擇該手術。

子宮腔鏡檢查最嚴重的風險之一是子宮穿孔，即子宮腔鏡刺穿子宮壁。儘管很少見，但這可能會導致出血、感染或附近器官受傷，需要立即介入。例如，根據美國國立衛生研究院發表的一項研究，子宮穿孔是子宮腔鏡手術最常見的併發症之一，發生率為0.8-1.5%。子宮穿孔可能在子宮頸擴張或插入子宮腔鏡期間發生。對此類併發症的恐懼可能會阻止患者選擇子宮腔鏡檢查，從而限制其採用，特別是在醫生經驗不足的環境中。

另一個重要的擔憂是手術過程中感染的可能性，特別是當外來器械被引入子宮時。感染可導致骨盆腔炎 (PID) 或子宮內膜炎等併發症，需要抗生素治療。儘管感染的風險很低，但它仍然可能導致再次入院、額外的治療和更長的恢復時間，這會影響患者的滿意度和手術的整體吸引力。

過度出血是子宮腔鏡手術期間可能出現的另一種併發症，特別是在子宮腔鏡手術（例如子宮肌瘤切除術或息肉切除術）中。雖然通常使用電外科器械控制出血，但在某些情況下，可能需要進一步的手術介入。

有關此報告的更多詳細資訊 - 索取樣本

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 婦科疾病盛行率上升
    • 限制
      • 併發症的風險
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：子宮腔鏡市場，依產品類型

  • 硬質子宮腔鏡
  • 軟性子宮腔鏡
  • 拋棄式子宮腔鏡

第 6 章：子宮鏡市場（按應用）

  • 子宮肌瘤切除術
  • 息肉切除術
  • 子宮內膜去除術
  • 其他

第 7 章：子宮鏡市場（依最終用戶）

  • 醫院
  • 婦科診所
  • 門診手術中心
  • 其他

第 8 章：子宮腔鏡市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 9 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 10 章：公司簡介

  • Olympus Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Stryker Corporation
  • Medtronic plc
  • Hologic, Inc.
  • KARL STORZ
  • Richard Wolf GmbH
  • Zhejiang Geyi Medical Instrument Co., Ltd
  • LiNA Medical ApS
  • Delmont imaging
  • Meditrina, Inc.

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MD1458

The global hysteroscopes market reached US$ 260.4 million in 2024 and is expected to reach US$ 424.00 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

A hysteroscope is a medical instrument used for visual examination of the interior of the uterus (womb). It is a type of endoscope specifically designed for gynecological procedures. The device consists of a thin, tubular structure that can be inserted through the cervix (the lower part of the uterus) into the uterus. It is typically equipped with a light source and a camera, allowing the physician to view the uterine lining on a monitor in real time. Hysteroscopy is typically performed in an outpatient or hospital setting under local or general anesthesia, depending on the complexity of the procedure. The hysteroscope is inserted through the cervix into the uterus, and carbon dioxide or saline solution may be used to expand the uterus to improve visibility.

The hysteroscope market is experiencing significant growth, driven by factors such as the increasing prevalence of gynecological disorders and rising advancements in hysteroscopes for minimally invasive procedures. For instance, in May 2024, Meditrina, a key leader in women's health medical devices, announced the FDA 510(k) clearance of its Gen 2 bipolar RF hysteroscopy system. This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecology disorders

The rising prevalence of gynecology disorders is significantly driving the growth of the hysteroscopes market and is expected to drive the market over the forecast period. Uterine fibroids, endometrial polyps and abnormal uterine bleeding are common gynecological conditions that often necessitate hysteroscopic evaluation and treatment. The global incidence of these conditions is rising due to factors such as age, lifestyle changes, and increased awareness.

For instance, according to the National Institute of Health (NIH), Uterine leiomyomas are one of the most common and yet understudied diseases in women. These tumors, commonly known as fibroids, affect women mainly during their reproductive years and are diagnosed in up to 70% of white women and more than 80% of women of African ancestry during their lifetime. Additionally, according to DynaMed, endometrial polyps are reported in 21%-28% of postmenopausal patients with abnormal uterine bleeding and in 10%-40 % of premenopausal patients with abnormal uterine bleeding.

Endometrial cancer (cancer of the uterine lining) is becoming more common, especially in postmenopausal women. For instance, according to the World Cancer Research Fund, there were 420,368 new cases of endometrial cancer in 2022, including China with 77,722, the United States with 66,055, Russia with 29,852, Japan with 18,338 and India with 17,240. Hysteroscopy is a key diagnostic tool for detecting endometrial cancer, and its use in biopsies and assessments of the uterine lining for abnormal growths is essential, increasing the demand for advanced hysteroscopic systems.

Risk of complications

The risk of complications associated with hysteroscopic procedures is a significant factor hampering the growth of the hysteroscope market. While hysteroscopy is generally considered minimally invasive and safe, it still carries certain risks that can deter both patients and healthcare providers from opting for the procedure.

One of the most serious risks of hysteroscopy is uterine perforation, where the hysteroscope punctures the wall of the uterus. Although rare, this can lead to bleeding, infection, or injury to nearby organs, requiring immediate intervention. For instance, according to a study published by the National Institute of Health, uterine perforation is one of the most common complications of operative hysteroscopy with an incidence of 0.8-1.5%. Uterine perforation can happen during cervical dilation or during insertion of the hysteroscope. The fear of such complications can discourage patients from choosing hysteroscopy, limiting its adoption, especially in settings with less experienced practitioners.

Another significant concern is the potential for infection during the procedure, especially when foreign instruments are introduced into the uterus. Infections can lead to complications like pelvic inflammatory disease (PID) or endometritis, requiring antibiotic treatment. Though the risk of infection is low, it can still lead to hospital readmissions, additional treatments, and longer recovery times, which impacts patient satisfaction and the overall appeal of the procedure.

Excessive bleeding is another complication that can arise during hysteroscopic procedures, particularly in operative hysteroscopy (e.g., myomectomy or polypectomy). While bleeding is often controlled with the use of electrosurgical instruments, in some cases, it can lead to a need for further surgical intervention.

For more details on this report - Request for Sample

Segment Analysis

The global hysteroscopes market is segmented based on product type, application, end-user and region.

Product Type:

The disposable hysteroscope segment is expected to dominate the hysteroscopes market share

One of the primary advantages of disposable hysteroscopes is their single-use design, which eliminates the risk of cross-contamination and infection that can occur with reusable instruments. After each use, disposable hysteroscopes are discarded, ensuring that they are sterile for every procedure. The World Health Organization (WHO) has highlighted the importance of reducing infection risks in medical procedures, which has significantly influenced the adoption of single-use instruments like disposable hysteroscopes. Thus, many market players are focusing on disposable hysteroscopes.

For instance, in May 2024, Minerva Surgical announced the immediate and exclusive distribution of a new disposable hysteroscope that will be displayed at the Annual Clinical & Scientific Meeting of the American College of Obstetricians and Gynecologists in San Francisco, CA. The company plans to soon rebrand the new disposable hysteroscope as HERizon, and its goal is to redefine the standards of efficiency and accessibility in gynecological care.

While reusable hysteroscopes require significant upfront investment and maintenance costs (cleaning, sterilization, repairs), disposable hysteroscopes have a lower cost for healthcare facilities and eliminate the ongoing expenses associated with maintaining reusable equipment. This cost-effectiveness is particularly attractive to smaller healthcare providers and those in developing regions, where budget constraints are a concern.

Geographical Analysis

North America is expected to hold a significant position in the hysteroscopes market share

North America especially in the United States, is home to many leading and emerging manufacturers of hysteroscopes, such as Olympus Corporation, Karl Storz, UroViu Corp and Stryker Corporation, which continually push the envelope on technological innovations in the field. Innovations in high-definition cameras, flexible hysteroscopes, and single-use disposable models have contributed to the growth of the hysteroscope market in the region, as these advancements improve the accuracy, safety, and convenience of procedures.

For instance, in June 2022, UroViu Corp launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations. The single-use hysteroscope eliminates the need for reprocessing the equipment, and the ease-of-use, portability, and time-saving aspects of the Hystero-V mean more efficient and comfortable procedures for both doctors and patients.

In North America, there is a high level of awareness around women's health, with strong healthcare campaigns focusing on early diagnosis and treatment of gynecological conditions. Institutions like the U.S. Department of Health and Human Services have launched programs targeting early detection of gynecological cancers, which drives the use of hysteroscopy for diagnosis and treatment. Public awareness campaigns, such as National Women's Health Week in the U.S., encourage women to undergo routine gynecological screenings, including hysteroscopy for conditions like abnormal uterine bleeding and fibroids.

Asia-Pacific is growing at the fastest pace in the hysteroscopes market

The Asia-Pacific region is witnessing an increase in the availability of advanced hysteroscopy technology, including high-definition cameras, flexible scopes, and disposable hysteroscopes. These innovations are enhancing the appeal of hysteroscopy in diagnosing and treating gynecological conditions with greater accuracy and minimal risk of infection. Countries like Japan and South Korea are leaders in adopting cutting-edge medical technologies, which are contributing to the growth of the hysteroscope market in the region.

In November 2022, India Medtronic Private Limited launched the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA). Some of the commonly seen IUA include fibroids, polyps, retained products of conception, adhesions, malignancies or hyperplasia.

Competitive Landscape

The major global players in the hysteroscopes market include Olympus Corporation, Stryker Corporation, Medtronic plc, Hologic, Inc., KARL STORZ, Richard Wolf GmbH, Zhejiang Geyi Medical Instrument Co., Ltd, LiNA Medical ApS, Delmont imaging, Meditrina, Inc. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hysteroscopes market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Gynecology Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Hysteroscopes Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Rigid Hysteroscope*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Flexible Hysteroscope
  • 5.4. Disposable Hysteroscope

6. Hysteroscopes Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Myomectomy*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Polypectomy
  • 6.4. Endometrial Ablation
  • 6.5. Others

7. Hysteroscopes Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gynecology Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Hysteroscopes Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Olympus Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. Stryker Corporation
  • 10.3. Medtronic plc
  • 10.4. Hologic, Inc.
  • 10.5. KARL STORZ
  • 10.6. Richard Wolf GmbH
  • 10.7. Zhejiang Geyi Medical Instrument Co., Ltd
  • 10.8. LiNA Medical ApS
  • 10.9. Delmont imaging
  • 10.10. Meditrina, Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us